The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur

The role that transduced mouse bone marrow stromal cells (mBMSCs) engineered to overexpress human bone morphogenetic protein 2 (BMP-2) play in healing critical-sized skeletal defects is largely unknown. We evaluated the interaction between host osteoprogenitor cells and donor mBMSCs transduced with either a lentiviral (LV) vector-expressing red fluorescent protein (RFP) with or without BMP-2 that were implanted into a critical-sized femoral defect. Radiographs taken at the time of killing were evaluated using a five-point scaled scoring system. Frozen histologic sections were analyzed to assess both the transduced cells’ role in bone repair and the local osteoprogenitor response. There was complete radiographic bridging in 94% of group I (LV-RFPch-BMP-2-cmyc) and 100% of group III (recombinant human BMP-2) specimens. Radiographs demonstrated a lack of healing in group II (LV-RFPch). Mouse BMSCs transduced with an LV-RFPch-BMP-2 vector were able to induce host cells to differentiate down an osteoblastic lineage and heal a critical-sized defect. However, the donor cells appeared to be functioning as a delivery vehicle of BMP-2 rather than actually differentiating into osteoblasts capable of participating in bone repair as evidenced by a lack of colocalization of the transduced cells to the sites of skeletal repair where the host progenitor cells were found.

[1]  H. Drissi,et al.  Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair , 2013, Gene Therapy.

[2]  T. Arinzeh,et al.  Characterization and differentiation potential of rabbit mesenchymal stem cells for translational regenerative medicine , 2013, In Vitro Cellular & Developmental Biology - Animal.

[3]  Alen Braut,et al.  Histological Analysis of GFP Expression in Murine Bone , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  P. Robbins,et al.  Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene , 2000, Gene Therapy.

[5]  I. Kalajzic,et al.  Utilization of transgenic models in the evaluation of osteogenic differentiation of embryonic stem cells , 2013, Connective tissue research.

[6]  K. Lyons,et al.  Tracking Expression of Virally Mediated BMP-2 in Gene Therapy for Bone Repair , 2006, Clinical orthopaedics and related research.

[7]  Freddie H Fu,et al.  Structural and functional healing of critical‐size segmental bone defects by transduced muscle‐derived cells expressing BMP4 , 2004, The journal of gene medicine.

[8]  B. Feeley,et al.  In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  Dong-Guk Shin,et al.  Computer-Automated Static, Dynamic and Cellular Bone Histomorphometry , 2012, Journal of tissue science & engineering.

[10]  J. Wozney,et al.  Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. , 1999, Journal of biomedical materials research.

[11]  D. Gazit,et al.  Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell‐mediated gene therapy , 1999, The journal of gene medicine.

[12]  Johnny Huard,et al.  Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. , 2002, Human gene therapy.

[13]  J. Hoyland,et al.  Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. , 2009, European cells & materials.

[14]  Marc Hedrick,et al.  Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. , 2005, Tissue engineering.

[15]  N. Otsu.  A threshold selection method from gray level histograms , 1979 .

[16]  D. Rowe,et al.  Evaluation of osteogenic cell differentiation in response to bone morphogenetic protein or demineralized bone matrix in a critical sized defect model using GFP reporter mice , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  Jeffrey C. Wang,et al.  Comparison of Lentiviral and Adenoviral Gene Therapy for Spinal Fusion in Rats , 2008, Spine.

[18]  T. Albert,et al.  Donor Site Morbidity After Anterior Iliac Crest Bone Harvest for Single-Level Anterior Cervical Discectomy and Fusion , 2003, Spine.

[19]  J. Huard,et al.  Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. , 2002, The Journal of bone and joint surgery. British volume.

[20]  S. Gambhir,et al.  "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  R. Guldberg,et al.  Biological effects of rAAV-caAlk2 coating on structural allograft healing. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Jeffrey C. Wang,et al.  Comparison of Human Mesenchymal Stem Cells Derived From Adipose Tissue and Bone Marrow for Ex Vivo Gene Therapy in Rat Spinal Fusion Model , 2008, Spine.

[23]  F. Kloss,et al.  Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes , 2003, Gene Therapy.

[24]  M. Chapman,et al.  Morbidity at bone graft donor sites. , 1989, Journal of orthopaedic trauma.

[25]  Douglas J Adams,et al.  Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  A Daluiski,et al.  The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. , 1999, The Journal of bone and joint surgery. American volume.

[27]  B. Feeley,et al.  Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  J. Li,et al.  Adenoviral‐mediated transfer of human BMP‐6 gene accelerates healing in a rabbit ulnar osteotomy model , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  I. Chen,et al.  A Murine Leukemia Virus (MuLV) Long Terminal Repeat Derived from Rhesus Macaques in the Context of a Lentivirus Vector and MuLVgag Sequence Results in High-Level Gene Expression in Human T Lymphocytes , 2000, Journal of Virology.

[31]  Hiromu Ito,et al.  Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy , 2005, Nature Medicine.

[32]  W. Hsu,et al.  Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. , 2007, Bone.

[33]  M. Liebergall,et al.  Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. , 2006, Tissue engineering.

[34]  M. Mastrogiacomo,et al.  Tissue engineering of bone: search for a better scaffold. , 2005, Orthodontics & craniofacial research.

[35]  J. Lieberman,et al.  Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. , 2008, Bone.